Sg3 Management, LLC Biogen Inc. Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.65 Million - $2.08 Million	8,500 Added 130.77%	15,000 $3.16 Million
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $1.12 Million - $1.44 Million	-5,000 Reduced 43.48%	6,500 $1.56 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $5.61 Million - $7.32 Million	-19,830 Reduced 63.29%	11,500 $3.25 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $5.35 Million - $6.27 Million	22,030 Added 236.88%	31,330 $8.77 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $2.2 Million - $3.31 Million	9,300 New	9,300 $2.28 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.